Covid 19 Vaccines Approval: What You Need to Know
Covid 19 Vaccines Approval Expected
The US Food and Drug Administration (FDA) is poised to approve updated Covid 19 vaccines as early as next week. The approval comes amid the country experiencing its largest summer wave in two years.
Details on the Updated Vaccines
- The FDA may authorize mRNA vaccines from Moderna and Pfizer/BioNTech targeting the KP.2 strain.
- It remains unclear if Novavax’s vaccine targeting JN.1 will be approved simultaneously.
- Officials recommend that everyone over 6 months get updated vaccines.
Vaccination Strategies
Dr. Michael Osterholm advises that now is the time to get vaccinated given the surge. He has received his dose while awaiting the updated vaccine available in four months. The CDC suggests simultaneous vaccinations for flu and Covid this year.
Supply and Readiness
Moderna and Pfizer have confirmed ample supply of the updated vaccines, ready for quick distribution upon FDA approval. Novavax, relying on a longer manufacturing process, anticipates its vaccine will be available shortly after authorization.
Current Covid-19 Situation
Recent CDC data shows SARS-CoV-2 levels in wastewater are at “very high” levels, indicating widespread infection. Hospitalization and death rates are rising but are not at past peak levels.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.